Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank64
3Y CAGR+60.6%
5Y CAGR+14.1%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
+60.6%/yr
Annual compound
5Y CAGR
+14.1%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.01-7.6%
20240.01+3324.8%
20230.00-86.9%
20220.00+62.7%
20210.00-71.3%
20200.00-47.7%
20190.01-
20180.00-
20170.00-100.0%
20160.35-